Market News AIOpen the app

NKTX stock news · Nkarta, Inc.

Stories about Nkarta, Inc. (NKTX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for NKTX

Follow Nkarta, Inc. (NKTX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for NKTX
Free on the App Store and Google Play, or on the web.
  1. Nov 9, 2026, 9:25 AM ET · Market

    Nkarta, Inc. shared early results for its NKX019 treatment for myositis and systemic sclerosis.

    Good for NKTX

    Nkarta reported responses in 5 of 6 myositis patients and 6 of 7 systemic sclerosis patients at 4 billion cells per dose. Early results favor Nkarta.